Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Biomarker Study for Head and Neck Cancer

NCT05375266 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.

NCT NCT05375266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05375266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Biomarker Study for Head and Neck Cancer
Lead sponsor
University of Erlangen-Nürnberg Medical School
Phase
Observational
Overall status
Recruiting
Start date
May 16, 2022
Completion date
March 31, 2027
Enrollment
1,100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, hypopharyngeal cancer, laryngeal cancer, oral cavity cancer, oropharyngeal cancer